Daniel Freedberg, MD, “Famotidine and COVID-19”

Columbia University - New York | May 20, 2020

Dr. Freedberg presented a retrospective analysis on Columbia patients on the use of Famotidine, the active ingredient in Pepcid AC, for mitigating COVID-19. The famotidine patients took a range of doses via IV (28%) or orally (72%) and they found that famotidine patients were less likely to die or be intubated.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!